View in EDS HTML Full Text PDF Full Text

Evaluation of the potential for QTc prolongation with avelumab.

Saved in:
Bibliographic Details
Title: Evaluation of the potential for QTc prolongation with avelumab.
Authors: Vugmeyster Y; Clinical Pharmacology, EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA, 01821, USA. yulia.vugmeyster@emdserono.com., Güzel G; Global Clinical Development Immuno-Oncology, Merck KGaA, Darmstadt, Germany., Hennessy M; Global Clinical Development, EMD Serono Research and Development Institute, Inc, Billerica, MA, USA., Loos AH; Global Biostatistics, Merck KGaA, Darmstadt, Germany., Dai H; Clinical Pharmacology, EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA, 01821, USA.
Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2019 Nov; Vol. 84 (5), pp. 1017-1026. Date of Electronic Publication: 2019 Sep 03.
Publication Type: Journal Article; Meta-Analysis
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31478078
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluation of the potential for QTc prolongation with avelumab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Vugmeyster+Y%22">Vugmeyster Y</searchLink>; Clinical Pharmacology, EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA, 01821, USA. yulia.vugmeyster@emdserono.com.<br /><searchLink fieldCode="AU" term="%22Güzel+G%22">Güzel G</searchLink>; Global Clinical Development Immuno-Oncology, Merck KGaA, Darmstadt, Germany.<br /><searchLink fieldCode="AU" term="%22Hennessy+M%22">Hennessy M</searchLink>; Global Clinical Development, EMD Serono Research and Development Institute, Inc, Billerica, MA, USA.<br /><searchLink fieldCode="AU" term="%22Loos+AH%22">Loos AH</searchLink>; Global Biostatistics, Merck KGaA, Darmstadt, Germany.<br /><searchLink fieldCode="AU" term="%22Dai+H%22">Dai H</searchLink>; Clinical Pharmacology, EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA, 01821, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227806519%22">Cancer chemotherapy and pharmacology</searchLink> [Cancer Chemother Pharmacol] 2019 Nov; Vol. 84 (5), pp. 1017-1026. <i>Date of Electronic Publication: </i>2019 Sep 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Meta-Analysis
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7806519 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0843 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203445704%22">03445704 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Chemother Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31478078
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00280-019-03925-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1017
    Titles:
      – TitleFull: Evaluation of the potential for QTc prolongation with avelumab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vugmeyster Y
      – PersonEntity:
          Name:
            NameFull: Güzel G
      – PersonEntity:
          Name:
            NameFull: Hennessy M
      – PersonEntity:
          Name:
            NameFull: Loos AH
      – PersonEntity:
          Name:
            NameFull: Dai H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2019 Nov
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0843
          Numbering:
            – Type: volume
              Value: 84
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Cancer chemotherapy and pharmacology
              Type: main
ResultId 1